© 2003 BMJ Publishing Group & British Thoracic Society
INTERSTITIAL LUNG DISEASE
Increased interleukin-13 expression in patients with sarcoidosis
Department of Internal Medicine, University Hospital Eppendorf, Hamburg, Germany
Correspondence to:
Correspondence to:
Dr H-P Hauber, Meakins-Christie Laboratories, 3626 St-Urbain Street, Montreal, Quebec H2X 2P2, Canada;
hans-peter.hauber{at}mcgill.ca
Background: Sarcoidosis is a systemic granulomatous disorder of unknown origin. Lymphocytic inflammation is dominated by expression of Th1 type cytokines such as tumour necrosis factor
(TNF
). Interleukin 13 (IL-13) is a Th2 cytokine which is expressed by CD4+ T cells and has been shown to suppress TNF
in human blood monocytes. The role of IL-13 as a possible anti-inflammatory cytokine in sarcoidosis was investigated.
Methods: mRNA expression of IL-13, IL-4, IL-10, and TNF
in bronchoalveolar lavage (BAL) fluid cells and peripheral mononuclear blood cells (PBM) of 18 patients with sarcoidosis and nine healthy controls was assessed using RT-PCR. In addition, IL-13 protein levels in BAL cell culture supernatants from 12 patients and all controls were measured and immunocytochemistry of IL-13 protein was performed in BAL fluid cells of eight patients. TNF
concentrations were measured with and without stimulation with recombinant human (rh) IL-13, rhIL-10, and lipopolysaccharide (LPS).
Results: IL-13 mRNA expression was significantly increased in BAL cells and PBM of patients compared with controls (p<0.05). No significant difference was found in IL-4 mRNA or IL-10 mRNA expression in BAL fluid cells or PBM between the two groups. TNF
mRNA expression was significantly higher in BAL fluid cells of patients than controls (p<0.05). IL-13 protein levels in BAL cell culture supernatants were slightly raised in half the patients investigated but in only two controls. Immunocytochemistry detected IL-13 protein in alveolar macrophages of patients. IL-13 led to decreased TNF
concentrations (p<0.05).
Conclusions: IL-13 expression is increased in BAL cells and PBM in sarcoidosis and IL-13 is secreted from BAL cells. Alveolar macrophages may be the cellular source. These data suggest that IL-13 might have an anti-inflammatory effect by acting on TNF
.
Keywords: interleukin-13; sarcoidosis; tumour necrosis factor 
Relevant Article
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Thorax 2003 58: 463.
This article has been cited by other articles:
-
Wenzel, S., Holgate, S. T.
(2006). The Mouse Trap: It Still Yields Few Answers in Asthma. Am. J. Respir. Crit. Care Med.
174: 1173-1176
[Full Text] -
Idali, F., Wiken, M., Wahlstrom, J., Mellstedt, H., Eklund, A., Rabbani, H., Grunewald, J.
(2006). Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis.. Eur Respir J
27: 451-459
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
